ArticleBMC medical genomics2024

ASXL1 truncating variants in BOS and myeloid leukemia drive shared disruption of Wnt-signaling pathways but have differential isoform usage of RUNX3.

Isabella Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.